Abstract
- Small bowel bleeding constitutes approximately 5%–10% of all gastrointestinal bleeding and remains a significant diagnostic challenge because of both the anatomical inaccessibility of the small intestine and the intermittent nature of bleeding. Although innovations such as capsule endoscopy and device-assisted enteroscopy have improved lesion detection, localization frequently fails when bleeding is obscure or transient. To address these diagnostic challenges, provocative mesenteric angiography (PMA) has been introduced as an adjunctive diagnostic modality. By dissolving microthrombi and preventing spontaneous hemostasis, PMA can reveal concealed bleeding sites that remain undetectable with other diagnostic techniques. This procedure carries inherent risks, including excessive bleeding, and therefore should be performed by experienced interventional radiologists within a multidisciplinary team capable of urgent surgical intervention if needed. The patient in this case had been taking long-term warfarin following cardiac valve replacement and presented with hematochezia. Although computed tomography angiography and endoscopic evaluation suggested small bowel bleeding, repeated examinations failed to identify the exact bleeding focus. Subsequently, using PMA with heparin, the bleeding focus in the ileum was successfully localized, hemostasis was achieved, and no rebleeding occurred thereafter.
-
Keywords: Angiography; Case reports; Hemorrhage; Small intestine
Introduction
- Small bowel bleeding accounts for approximately 5%–10% of all gastrointestinal bleeding; its anatomical inaccessibility and intermittent nature make diagnosis and subsequent management challenging [1]. Advancements in diagnostic modalities, including small bowel capsule endoscopy and device-assisted enteroscopy, have significantly improved the detection rate of small bowel lesions. However, in cases of intermittent or occult bleeding, accurately localizing the bleeding source remains challenging [2]. In patients receiving anticoagulants such as warfarin, the risk of recurrent bleeding is high; however, discontinuation of anticoagulation increases the risk of thromboembolic events, thereby creating a clinical dilemma.
- Conventional angiography is effective for identifying active bleeding; however, it often fails to detect the bleeding site because the bleeding typically subsides by the time of examination [3]. Provocative mesenteric angiography (PMA) has been proposed as a technique to overcome these constraints [3,4]. Here, we report a case of recurrent small bowel bleeding in a patient receiving long-term warfarin therapy after cardiac valve replacement surgery, in which the bleeding source was successfully localized and treated using PMA with heparin.
Case
-
Ethical statements: This study was reviewed and approved by the Institutional Review Board (IRB) of Pusan National University Hospital (IRB No. 2510-020-156). The IRB approved a waiver of written informed consent.
- A 58-year-old female patient presented to the emergency department with hematochezia. She had undergone mitral and aortic valve replacement and tricuspid annuloplasty 23 years ago, followed by tricuspid valve replacement 6 years prior. She had right-sided heart failure and atrial fibrillation, complicated by cardiogenic liver cirrhosis secondary to chronic cardiac disease. Additional comorbidities included type 2 diabetes mellitus and hypothyroidism. She was on long-term warfarin therapy for atrial fibrillation.
- On presentation, her vital signs were as follows: blood pressure 100/60 mmHg, pulse rate 120 beats/min, respiratory rate 18 breaths/min, body temperature 37.0 °C, and oxygen saturation 99%. Physical examination revealed tachycardia and conjunctival pallor. Digital rectal examination demonstrated fresh blood, whereas abdominal examination was unremarkable.
- Laboratory tests revealed a white blood cell count of 9,340/μL, hemoglobin level of 5.5 g/dL, and platelet count of 192,000/μL. Serum chemistry findings were as follows: aspartate aminotransferase 21 IU/L, alanine aminotransferase 6 IU/L, total bilirubin 1.19 mg/dL, total protein 6.80 g/dL, albumin 4.07 g/dL, and creatinine 0.99 mg/dL. Coagulation studies revealed a markedly prolonged prothrombin time of 47.2 seconds and an international normalized ratio (INR) of 4.59. Plain abdominal radiography revealed no specific abnormal findings.
- Given the markedly elevated INR, correction of coagulopathy was prioritized. The patient received red blood cell and fresh frozen plasma transfusions and intravenous vitamin K. Despite these interventions, hematochezia persisted. Esophagogastroduodenoscopy (EGD) and sigmoidoscopy were subsequently performed. EGD revealed no abnormalities, whereas sigmoidoscopy demonstrated continuous fresh blood originating from the proximal colon or a more proximal source. Contrast-enhanced abdominal computed tomography (CT) revealed active contrast extravasation in the mid-ileum, consistent with small bowel bleeding. Emergency angiography was performed; however, no definite bleeding site was identified; therefore, embolization was not performed.
- Following angiography, hematochezia spontaneously ceased, and the patient remained hemodynamically stable with supportive care. However, after 5 days, hematochezia recurred. Small bowel capsule endoscopy revealed fresh blood extending from the mid to distal ileum, although the exact bleeding focus could not be visualized due to a large volume of intraluminal blood (Fig. 1). Subsequently, single-balloon assisted enteroscopy was performed through the per-anal route to localize the bleeding source and perform hemostasis if required. During the procedure, blood clots and multiple angioectasias were observed from the mid to terminal ileum, but no active bleeding site was identified; thus, no endoscopic hemostasis was performed (Fig. 2).
- Three days after enteroscopy, the patient again developed melena and hematochezia. Repeat contrast-enhanced abdominal CT failed to identify the bleeding source. Subsequently, she experienced another similar bleeding episode, and an additional repeated contrast-enhanced CT was performed; however, the bleeding focus could not be identified again. Owing to recurrent episodes of bleeding, anticoagulation had been withheld for a prolonged period. Despite supportive therapy, intermittent small bowel bleeding persisted, and repeated diagnostic attempts were inconclusive because the bleeding had often ceased at the time of evaluation. Further delay in resuming anticoagulant therapy posed a significant risk of fatal thromboembolic and cardiac complications related to her underlying cardiac valvular disease. Consequently, a PMA using heparin was planned. A surgical team was on standby for potential emergency surgery.
- Before angiography, a 5,000-unit intravenous bolus of heparin was administered, followed by continuous infusion at 800 units per hour. Angiography revealed active contrast extravasation from an ileal branch of the superior mesenteric artery. Superselective embolization was successfully performed using a histoacryl-lipiodol mixture (Fig. 3). Heparin infusion was discontinued immediately after embolization.
- Following the procedure, no further bleeding occurred. During an 18-month follow-up period after discharge, the patient remained clinically stable without recurrence of bleeding. The patient’s clinical course by hospital day is summarized in Fig. 4.
Discussion
- This case illustrates a rare instance of recurrent small bowel bleeding in a patient receiving long-term warfarin therapy after cardiac valve replacement, in whom the bleeding source was successfully identified and treated by embolization through PMA using heparin. Common causes of small bowel bleeding include vascular lesions, drug-induced enteropathy, tumors, inflammatory bowel disease, and Meckel’s diverticulum [5]. Among vascular lesions, angiodysplasia is a frequent cause, particularly in elderly patients, those with cardiac disease, patients receiving anticoagulant therapy, and those with multiple lesions. The risk of rebleeding increases further in patients with multiple lesions, concomitant anticoagulation, or liver cirrhosis [6].
- In this case, conventional endoscopic and radiologic evaluations failed to identify the active bleeding site, complicating diagnosis. CT angiography can detect active bleeding when the rate exceeds 0.3–0.5 mL/min; however, in this case, no bleeding focus was identified on CT angiography [7]. Although discontinuation of warfarin was unavoidable, prolonged interruption carried a substantial risk of valve-related complications. In this patient, who had cardiogenic liver cirrhosis secondary to valvular heart disease, such complications could have been life-threatening. Therefore, active localization and treatment of the bleeding source were essential, and PMA using heparin was chosen as a targeted diagnostic and therapeutic approach.
- PMA is a useful diagnostic method for detecting bleeding sources in patients with intermittent or obscure gastrointestinal bleeding. The technique induces bleeding by disrupting microthrombi, reversing transient hemostasis, thereby facilitating visualization of active extravasation during angiography. However, because of the risk of increased bleeding during the procedure, it requires experienced operators and close multidisciplinary coordination. Specifically, prearrangement with surgeons is essential to facilitate prompt surgical intervention in the event of massive bleeding. Previous reports indicate that, in addition to heparin, thrombolytic agents and vasodilators can also be used for provocation. Vasodilators increase intravascular blood flow, boosting the delivery of thrombolytic agents and enhancing visualization of contrast extravasation during angiography. Thrombolytic agents dissolve clots that occlude bleeding vessels, inducing rebleeding, whereas heparin prevents hemostasis of the induced bleeding [3,4]. In our case, PMA was commenced using only heparin. This decision was made because the patient’s poor general condition raised concerns about potential severe bleeding complications, and because the procedure was performed at a time when bleeding had already occurred, making the suppression of spontaneous hemostasis adequate. Therefore, thrombolytic agents and vasodilators were prepared but were not administered. No standardized protocols exist for drug selection in PMA, although several previous reports have described procedures using heparin alone. However, the number of reported cases using heparin alone remains considerably smaller than those employing other pharmacologic agents [3]. The choice of pharmacologic agent should thus be individualized, considering the patient’s clinical condition and risk profile, as in our case.
- It may be questioned whether the bleeding source could have been identified even without the administration of heparin. However, as described above, repeated evaluations performed during episodes of hematochezia or melena consistently failed to detect the bleeding focus because spontaneous hemostasis had already occurred by the time of examination. In this context, the fact that the bleeding site became identifiable immediately after heparin administration suggests that heparin likely played a critical role in revealing the bleeding source.
- The reported diagnostic yield of PMA for identifying bleeding lesions is 48.7% [3]. In this case, if PMA had failed to localize the bleeding source, we intended to proceed with intraoperative enteroscopy for comprehensive assessment of the small intestine and potential surgical resection of the bleeding site. Despite the published 30-day rebleeding rate of 15.7% following successful embolization for lower gastrointestinal bleeding, this patient experienced no rebleeding throughout an 18-month follow-up period [8].
- In conclusion, this case demonstrates that PMA can serve as an effective diagnostic modality for recurrent small bowel bleeding, facilitating successful hemostasis through targeted embolization. In addition, PMA using heparin alone has not yet been extensively studied, and further research and accumulated clinical experience are needed. This case may serve as an important reference for future investigations.
Article information
-
Conflicts of interest
No potential conflict of interest relevant to this article was reported.
-
Funding
This work was supported by a 2-Year Research Grant of Pusan National University.
-
Author contributions
Conceptualization: SK, SMH. Data curation: SK, DHB, DCJ, JL, KY. Supervision: SMH, GAS, DHB. Writing–original draft: SK, DHB, DCJ, JL, KY. Writing–review & editing: SMH, GAS, DHB, DCJ. All authors read and approved the final manuscript.
Fig. 1.A large amount of fresh blood was observed in the ileum on small bowel capsule endoscopy.
Fig. 2.Single-balloon assisted enteroscopy revealed multiple angioectasias (arrows) from the mid-ileum to the terminal ileum (A, B), along with blood clots (C). However, no active bleeding was observed.
Fig. 3.Selective superior mesenteric artery (SMA) angiography after pharmacological provocation with heparin showed active bleeding (arrow) from an ileal branch of the SMA (A). After selective embolization of the ileal branch using a histoacryl:lipiodol mixture (1:3), angiography demonstrated no evidence of active extravasation (B).
Fig. 4.Clinical course by hospital day. HD, hospital day; EGD, esophagogastroduodenoscopy; CT, computed tomography; PMA, provocative mesenteric angiography.
References
- 1. Murphy B, Winter DC, Kavanagh DO. Small bowel gastrointestinal bleeding diagnosis and management: a narrative review. Front Surg 2019;6:25.ArticlePubMedPMC
- 2. Kim SH. Radiologic diagnosis of gastrointestinal bleeding. J Korean Soc Radiol 2023;84:520–35.ArticlePubMedPMCPDF
- 3. Hegde S, Sutphin PD, Zurkiya O, Kalva SP. Provocative mesenteric angiography for occult gastrointestinal bleeding: a systematic review. CVIR Endovasc 2023;6:42.ArticlePubMedPMCPDF
- 4. Kim CY. Provocative mesenteric angiography for diagnosis and treatment of occult gastrointestinal hemorrhage. Gastrointest Interv 2018;7:150–4.Article
- 5. Gunjan D, Sharma V, Rana SS, Bhasin DK. Small bowel bleeding: a comprehensive review. Gastroenterol Rep (Oxf) 2014;2:262–75.ArticlePubMedPMC
- 6. Grooteman KV, Holleran G, Matheeuwsen M, van Geenen EJM, McNamara D, Drenth JP. A risk assessment of factors for the presence of angiodysplasias during endoscopy and factors contributing to symptomatic bleeding and rebleeds. Dig Dis Sci 2019;64:2923–32.ArticlePubMedPMCPDF
- 7. Di Serafino M, Iacobellis F, Schilliro ML, Dell’Aversano Orabona G, Martino A, Bennato R, et al. The role of CT-angiography in the acute gastrointestinal bleeding: a pictorial essay of active and obscure findings. Tomography 2022;8:2369–402.ArticlePubMedPMC
- 8. Chevallier O, Comby PO, Guillen K, Pellegrinelli J, Mouillot T, Falvo N, et al. Efficacy, safety and outcomes of transcatheter arterial embolization with N-butyl cyanoacrylate glue for non-variceal gastrointestinal bleeding: a systematic review and meta-analysis. Diagn Interv Imaging 2021;102:479–87.ArticlePubMed
Citations
Citations to this article as recorded by
